XML 50 R40.htm IDEA: XBRL DOCUMENT v3.19.1
FINANCIAL INFORMATION Financial Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Apr. 08, 2019
Mar. 31, 2018
Mar. 31, 2019
Dec. 31, 2018
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification   $ 104,550    
Inventory, Net     $ 34,328 $ 32,956
Assets     299,670 265,843
Accounts receivable, net of allowances of $1,339 and $1,339 at March 31, 2019 and December 31, 2018, respectively     61,318 67,754
Long-term deferred revenues     13,361 13,939
Liabilities     466,757 432,504
Deferred Revenue, Current     87,927 85,662
Accumulated deficit     (1,187,223) (1,187,010)
Stockholders' Equity Attributable to Parent     $ (167,087) $ (166,661)
Subsequent Event [Member] | Cerberus Business Finance LLC [Member]        
Debt Instrument, Description On April 8, 2019, we entered into an amendment to our existing agreement (the “Financing Agreement”) with Cerberus Business Finance, LLC, as collateral and administrative agent, and the lenders party thereto. The amendment provides for an additional delayed draw term loan commitment in the aggregate principal amount of $100 million (the “Delayed Draw Funds”), which may be used to fund the purchase of our 2.00% Senior Convertible Notes due 2020 (the “Notes”). On May 2, 2019, we received the Delayed Draw Funds under the Financing Agreement. The Delayed Draw Funds will remain available to us to purchase Notes for a period of 90 calendar days. At the end of such 90-day period, any remaining Delayed Draw Funds that have not been used to purchase Notes must be repaid and no further funds will be available to borrow under the commitment. Any Delayed Draw Funds drawn and used to fund the purchase of the Notes will mature on May 10, 2023, the current maturity date under the Financing Agreement. Under the terms of the amendment, interest accrues on the Delay Draw Funds and the existing outstanding borrowings under the Financing Agreement at a rate of either the LIBOR Rate (as defined in the Financing Agreement) plus 6.25% or a Reference Rate (as defined in the Financing Agreement) plus 5.25%, at our option.